Quality and Safety

Costs per single treatment for drugs administered in hospitals were an average of $7,000 more than those purchased through specialty pharmacies.

This week's top stories include the Mayo Clinic halting the scheduling of appointments for patients in most Medicare Advantage plans, and an Oklahoma City hospital tightening security after COVID-19-related social media posts accused providers of murder.

Sara Serritella of the University of Chicago will spin her tale during the HIMSS22 annual conference in Orlando next month.

The ratings, which will be released in July, will not impact 2022 payment determinations, CMS says. 

The FDA is looking at additional data on a booster dose in children 6 months to 4 years old.

AHIP agreed that more clinical-trial-based evidence is needed on Aduhelm's benefits and the potential risks to patients.

The Eli Lilly drug awaits emergency use authorization from the FDA.

An effective way to combat workplace injury and illness, said OSHA, is to create and use a proactive safety and health program.

The biggest noncompliance was non-posting or incomplete posting of all of the negotiated prices for each item and service.

SD Biosensor said it has initiated an investigation to determine how the product was illegally imported into the U.S.